Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Authors = Jeffrey Blanzy

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
28 pages, 1257 KiB  
Review
Liquid Embolic Agents for Endovascular Embolization: A Review
by Amrita Pal, Jeffrey Blanzy, Karime Jocelyn Rosas Gómez, Mark C. Preul and Brent L. Vernon
Gels 2023, 9(5), 378; https://doi.org/10.3390/gels9050378 - 4 May 2023
Cited by 34 | Viewed by 7630
Abstract
Endovascular embolization (EE) has been used for the treatment of blood vessel abnormalities, including aneurysms, AVMs, tumors, etc. The aim of this process is to occlude the affected vessel using biocompatible embolic agents. Two types of embolic agents, solid and liquid, are used [...] Read more.
Endovascular embolization (EE) has been used for the treatment of blood vessel abnormalities, including aneurysms, AVMs, tumors, etc. The aim of this process is to occlude the affected vessel using biocompatible embolic agents. Two types of embolic agents, solid and liquid, are used for endovascular embolization. Liquid embolic agents are usually injectable and delivered into the vascular malformation sites using a catheter guided by X-ray imaging (i.e., angiography). After injection, the liquid embolic agent transforms into a solid implant in situ based on a variety of mechanisms, including polymerization, precipitation, and cross-linking, through ionic or thermal process. Until now, several polymers have been designed successfully for the development of liquid embolic agents. Both natural and synthetic polymers have been used for this purpose. In this review, we discuss embolization procedures with liquid embolic agents in different clinical applications, as well as in pre-clinical research studies. Full article
Show Figures

Graphical abstract

Back to TopTop